Enable Radioligand Therapy Access Worldwide.
- Raised
- $650
- Goal
- $200,000
Help us achieve our OBJECTIVE 365 LIVES by supporting 365 cancer patients over the next 5 years, representing a total of 10 million euros!
Through collaborative efforts, we can achieve this mission.
The RLT*-Connect Platform is an online tool that enables global donations of radiopharmaceutical-based cancer treatments, and thus, broaden the access to essential therapy for patients facing financial barriers. Radioisotope suppliers, local radiopharmacies and nuclear medicine services are already on board. Are you?
Radioligand therapy (RLT) is a targeted medical treatment that uses radioactive molecules to selectively deliver radiation directly to cancer cells. More and more RLTs are under development, and their adoption is steadily increasing as ongoing research continues to demonstrate their potential benefits in improving patient outcomes.*
This Fund allows U.S. donors an income tax deduction (501(c)(3)) for their contributions, to the extent permitted by U.S. tax law. Any questions related to tax deduction please contact us: contact@oncidium-life.org
THE ONCIDIUM FOUNDATION
The Oncidium foundation is a non-profit, public benefit organization that aims to support and accelerate the development of radiotheranostics for cancer care, worldwide. For more information, visit the Oncidium foundation website: OncidiumFoundation.org